QKACX
Price
$51.61
Change
+$0.21 (+0.41%)
Updated
Oct 17 closing price
Net Assets
2.72B
RWEBX
Price
$66.32
Change
+$0.27 (+0.41%)
Updated
Oct 17 closing price
Net Assets
205.87B
Interact to see
Advertisement

QKACX vs RWEBX

Header iconQKACX vs RWEBX Comparison
Open Charts QKACX vs RWEBXBanner chart's image
Federated Hermes MDT All Cap Core R6
Price$51.61
Change+$0.21 (+0.41%)
VolumeN/A
Net Assets2.72B
American Funds Washington Mutual R2E
Price$66.32
Change+$0.27 (+0.41%)
VolumeN/A
Net Assets205.87B
QKACX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
QKACX vs. RWEBX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKACX is a Hold and RWEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 206B vs. QKACX (2.72B). RWEBX pays higher dividends than QKACX: RWEBX (0.76) vs QKACX (0.40). QKACX was incepted earlier than RWEBX: QKACX (19 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than QKACX (0.85). QKACX is a more actively managed with annual turnover of: 71.00 vs. RWEBX (29.00). QKACX has a lower initial minimum investment than RWEBX: QKACX (0) vs RWEBX (250). QKACX annual gain was more profitable for investors over the last year : 8.82 vs. RWEBX (3.29). QKACX return over 5 years is better than : 60.50 vs. RWEBX (45.88).
QKACXRWEBXQKACX / RWEBX
Total Expense Ratio0.741.0670%
Annual Report Gross Expense Ratio0.851.0680%
Fund Existence19 years11 years-
Gain YTD15.5629.079171%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.72B206B1%
Annual Yield % from dividends0.400.7652%
Returns for 1 year8.823.29268%
Returns for 3 years64.7738.78167%
Returns for 5 years60.5045.88132%
Returns for 10 years160.6873.45219%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
PBI11.270.13
+1.17%
Pitney Bowes
PTLO5.900.02
+0.34%
Portillo's
BRRWU10.76-0.03
-0.28%
Columbus Circle Capital Corp I
MTSI136.82-1.12
-0.81%
MACOM Technology Solutions Holdings